This past fall saw considerable progress in the development of GBM AGILE, the brain cancer clinical trial initiative whose early-stage planning has long been supported by the Asian Fund for Cancer Research. Not only was an acting head hired to run the Global Coalition for Adaptive Research (GCAR), the non-profit…...
Hong Kong Cancer Day-A Look Back
The Asian Fund for Cancer Research was proud to have been among the 50-plus organizations and companies to have participated in the Hong Kong Anti-Cancer Society’s Hong Kong Cancer Day activities, held Sunday, 2018-12-9, at the Piazza of Kowloon Park in Tsim Sha Tsui. A full slate of family-friendly programming,…...
Hong Kong Cancer Day
On 2018-12-09, the Asian Fund for Cancer Research will be supporting and participating in the Hong Kong Anti-Cancer Society’s full day of Hong Kong Cancer Day programming. Actress Sonija Kwok will be serving as event ambassador, and among the special guests will be Hong Kong Secretary of Food and Health…...
Breakthrough drug co-developed by Hong Kong research team offers hope of longer life to brain cancer sufferers
Wang Jiguang (left), assistant professor at the division of life science, department of chemical and biological engineering, HKUST, and Professor Jiang Tao (right) from Beijing Tiantan Hospital, showing results of the clinical trial. Photo: Hong Kong University of Science and Technology Researchers at Hong Kong University of Science and Technology…...
2018 USCACA-AFCR Young Investigator Award
The 2018 USCACA-AFCR Scholar Award Ceremony in Tianjin on November 17, 2018 The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly awarded six outstanding Chinese cancer researchers in the early stage of their careers with the 2018 USCACA-AFCR Young Investigator Award. Scholars will each receive…...
USCACA & AFCR 2018 Scholar Awards
The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2018 Scholar Awards. The Awards will recognize 4 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research. Candidacy is open to all Chinese researchers who were trained…...
AFCR April 2018 China Brain Cancer Round Table
(clockwise) AFCR Founder and CEO Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin Bringing International Partners Together In recent months, the Asian Fund for Cancer Research (AFCR) has established relationships with two fellow Pacific Rim institutions: the China Pharmaceutical Innovation and Research Development…...
Two Giants of Cancer Care® with AFCR Affiliation
Respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice were recognized on June 31st as Giants of Cancer Care in an event at the Adler Planetarium in Chicago. Two of the 21 honorees are Scientific Advisory Board members of the Asian…...
Second Annual Meeting of Society for Neuro-Oncology of China (SNOChina 2018)
March 16-17, 2018 Changsha, Hunan, People’s Republic of China The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the founder and chief executive officer of the Asian Fund for Cancer Research (AFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha, Hunan on…...
